These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 20051564)

  • 1. Hormonal therapy for prostate cancer in men with heart disease.
    Agarwal N
    JAMA; 2010 Jan; 303(1):32-3; author reply 33. PubMed ID: 20051564
    [No Abstract]   [Full Text] [Related]  

  • 2. Duration of testosterone suppression and the risk of death from prostate cancer in men treated with radiation and 6 months of hormone therapy.
    Palma D; Pickles T
    Cancer; 2008 May; 112(10):2322-3; author reply 2323. PubMed ID: 18327816
    [No Abstract]   [Full Text] [Related]  

  • 3. Secondary hormonal manipulations in the management of advanced prostate cancer.
    Chaudhary UB; Rashid MH; Onitilo AA; Bissada NK
    Can J Urol; 2005 Jun; 12(3):2666-76. PubMed ID: 16011813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of short course hormonal therapy on overall and cancer specific survival after permanent prostate brachytherapy.
    Beyer DC; McKeough T; Thomas T
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1299-305. PubMed ID: 15817331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. StatBite: Cause of Death Among Prostate Cancer Patients by Gleason Score.
    J Natl Cancer Inst; 2009 May; 101(9):623. PubMed ID: 19401547
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary androgen deprivation therapy in men with prostate cancer.
    Laufman L
    JAMA; 2009 Jan; 301(1):35; author reply 35. PubMed ID: 19126809
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hormone therapy of locally advanced and metastatic prostate carcinoma].
    Rübben H
    Praxis (Bern 1994); 2001 Sep; 90(38):1641-4. PubMed ID: 11675917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Quality of life of patients with prostatic cancer under hormonal therapy].
    Aliaev IuG; Aslamazov EG; Demidko IuL
    Urologiia; 2010; (1):46, 48-51. PubMed ID: 20891045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depression related to (neo)adjuvant hormonal therapy for prostate cancer.
    van Tol-Geerdink JJ; Leer JW; van Lin EN; Schimmel EC; Stalmeier PF
    Radiother Oncol; 2011 Feb; 98(2):203-6. PubMed ID: 21256610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal therapy for prostate cancer in men with heart disease.
    Edwards JL
    JAMA; 2010 Jan; 303(1):32; author reply 33. PubMed ID: 20051565
    [No Abstract]   [Full Text] [Related]  

  • 11. Timing of salvage hormonal therapy in prostate cancer patients with unfavorable prognosis treated with radiotherapy: a secondary analysis of Radiation Therapy Oncology Group 85-31.
    Souhami L; Bae K; Pilepich M; Sandler H
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1301-6. PubMed ID: 20356687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Managing side effects of androgene deprivation in prostate cancer].
    Thalgott M; Gschwend JE; Retz M
    MMW Fortschr Med; 2010 Oct; 152(41):40-3. PubMed ID: 21090376
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of locally spread prostate cancer].
    Tammela T
    Duodecim; 2005; 121(16):1779-82. PubMed ID: 16268225
    [No Abstract]   [Full Text] [Related]  

  • 14. Ketoconazole as a secondary hormonal intervention in advanced prostate cancer.
    Liebertz C; Fox P
    Clin J Oncol Nurs; 2006 Jun; 10(3):361-6. PubMed ID: 16789581
    [No Abstract]   [Full Text] [Related]  

  • 15. Low dose of ketoconazole in patients with prostate adenocarcinoma resistant to pharmacological castration.
    Procopio G; Guadalupi V; Giganti MO; Mariani L; Salvioni R; Nicolai N; Capone F; Valdagni R; Bajetta E
    BJU Int; 2011 Jul; 108(2):223-7. PubMed ID: 21078047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating asymptomatic patients with hormone-refractory prostate cancer: hormonal manipulations for the urologist.
    Boudreaux KJ; Chang SS
    BJU Int; 2008 Mar; 101(6):671-4. PubMed ID: 18070172
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of prostate cancer with hormonal therapy in Europe.
    Miller K; Anderson J; Abrahamsson PA
    BJU Int; 2009 Mar; 103 Suppl 2():2-6. PubMed ID: 19228146
    [No Abstract]   [Full Text] [Related]  

  • 18. Advancements in radiotherapy and improved outcomes in prostate cancer.
    Milito SJ; Thomas CR; Turrisi AT
    J S C Med Assoc; 1998 Jun; 94(6):257-62. PubMed ID: 9648407
    [No Abstract]   [Full Text] [Related]  

  • 19. [Castration of prostate cancer patients and cognition].
    Portin R; Koskinen A; Helenius H; Nurmi M; Salminen E
    Duodecim; 2005; 121(16):1784-5. PubMed ID: 16268226
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostate cancer: the role of hormonal therapy.
    Salesi N; Carlini P; Ruggeri EM; Ferretti G; Bria E; Cognetti F
    J Exp Clin Cancer Res; 2005 Jun; 24(2):175-80. PubMed ID: 16110748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.